On November 9, ILUVATAR COREX rose 3.04% in Regular Trading, trading at HK$63.9, with turnover of HK$84.42 million.
The latest market-moving context points to continued investor attention on the company’s recently disclosed TianGai 300 test results. Public disclosures indicated that under a typical PD-separated deployment, normalized single-card end-to-end throughput reached 1.05 times that of an international mainstream top-tier GPU, while the IXL144 supernode could reduce cost per million effective tokens by about 40% versus mainstream international solutions.
Additional disclosed operating data also supported sentiment: chip shipments exceeded 80,000 units in the first ten months, and first-half revenue reached RMB945.7 million, up 191.6% year over year. The combination of product validation, cost efficiency and shipment growth has remained the main publicly visible backdrop for the stock’s recent activity.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments